Shark cartilage (AE-941, Neovastat)
The idea that sharks do not get cancer (they do) launched a supplement industry. Two randomised trials, including a large phase 3 in lung cancer, found that shark cartilage extract does nothing for survival, and the trade contributed to shark population declines.
Overview
Shark cartilage was promoted in the 1990s as an angiogenesis inhibitor after a popular book claimed sharks were immune to cancer. A randomised placebo-controlled trial of powdered shark cartilage in 83 patients with advanced breast or colorectal cancer (Loprinzi et al., 2005) found no effect on survival or quality of life, and the phase 3 trial of the standardised liquid extract AE-941 (Neovastat) in 379 patients with stage III non-small-cell lung cancer receiving chemoradiotherapy (Lu et al., JNCI 2010) found no difference in overall survival (14.4 versus 15.6 months). The NCI PDQ summary rates the evidence as showing no benefit. Products are unpleasant to take, have caused hepatitis in case reports, and the harvest has affected shark populations.
How it works
Cartilage contains proteins that inhibit angiogenesis in vitro; oral extracts are digested and do not deliver them to tumours.
- Adequately powered trials give a clear answer
- No benefit in randomised phase 3
- Unpleasant, occasionally hepatotoxic
- Ecological harm
Latest papers
topQuery for this technology: (TITLE:"Shark cartilage" OR ABSTRACT:"Shark cartilage" OR TITLE:"AE-941, Neovastat" OR ABSTRACT:"AE-941, Neovastat") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Shark cartilage (AE-941, Neovastat), not a curated reading list.
Pages like this
not linked directly; found by shared links- TechnologyHydrazine sulfate
Shares Evidence-based integrative oncology, Misinformation and unproven therapies, Failures are hidden, Colorectal cancer and the tags complementary, supportive-care, evidence:no-benefit.
- TechnologyMistletoe extracts (Iscador, Helixor)
Shares Evidence-based integrative oncology, Misinformation and unproven therapies, Failures are hidden, HR-positive / HER2-negative breast cancer and the tags complementary, supportive-care.
- TechnologyAntineoplastons (Burzynski clinic)
Shares Evidence-based integrative oncology, Misinformation and unproven therapies, Failures are hidden and the tags complementary, supportive-care.
- Key paperUse of alternative medicine for cancer and its impact on survival
Shares Evidence-based integrative oncology, Misinformation and unproven therapies, Colorectal cancer, HR-positive / HER2-negative breast cancer and the tag complementary.
- TechnologyReiki, healing touch and other energy therapies
Shares Evidence-based integrative oncology, Misinformation and unproven therapies and the tags complementary, supportive-care.
- TechnologyCurcumin and turmeric
Shares Evidence-based integrative oncology, Misinformation and unproven therapies and the tags complementary, supportive-care.
- TechnologyEssiac, Hoxsey and other 'herbal cancer cures'
Shares Evidence-based integrative oncology, Misinformation and unproven therapies and the tags complementary, supportive-care.
- TechnologyLaetrile (amygdalin, 'vitamin B17')
Shares Evidence-based integrative oncology, Misinformation and unproven therapies and the tags complementary, supportive-care.